Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Loh

Showing results (181-190 of 211) with videos related to

Pageof 22
Sort By:
Elife|January 30, 2024
Targeting sex determination to suppress mosquito populationsMing Li, Nikolay P Kandul, Ruichen Sun, et al.
Nature Communications|November 22, 2016
Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitorsHui Cheng, Heather Yin-Kuan Ang, Chadi A El Farran, et al.
Clinical Endocrinology|October 15, 2020
Outcomes in unilateral primary aldosteronism after surgical or medical therapyTroy H Puar, Lih M Loh, Wann J Loh, et al.
Nature Communications|July 25, 2022
Warming and redistribution of nitrogen inputs drive an increase in terrestrial nitrous oxide emission factorE Harris, L Yu, Y-P Wang, et al.
Circulation Research|August 12, 2021
Dach1 Extends Artery Networks and Protects Against Cardiac InjuryBrian Raftrey, Ian Williams, Pamela E Rios Coronado, et al.
Journal of the Endocrine Society|September 20, 2021
Tolerability and Efficacy of Long-Term Medical Therapy in Primary AldosteronismFengjie Tang, Lih M Loh, Roger S Foo, et al.
Cancer Discovery|November 20, 2025
DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell FrequencyThomas Köhnke, Daiki Karigane, Eleanor Hilgart, et al.
Blood Cancer Discovery|October 30, 2025
Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AMLDaiki Karigane, Amy C Fan, Toshinobu Nishimura, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
DNMT3A<sup>R882H</sup> Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell FrequencyThomas Köhnke, Daiki Karigane, Eleanor Hilgart, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
Phthalazinones. Part 1: The design and synthesis of a novel series of potent inhibitors of poly(ADP-ribose)polymeraseVincent M Loh, Xiao-ling Cockcroft, Krystyna J Dillon, et al.
Pageof 22

Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
Elife|January 30, 2024
Targeting sex determination to suppress mosquito populationsMing Li, Nikolay P Kandul, Ruichen Sun, et al.
Nature Communications|November 22, 2016
Reprogramming mouse fibroblasts into engraftable myeloerythroid and lymphoid progenitorsHui Cheng, Heather Yin-Kuan Ang, Chadi A El Farran, et al.
Clinical Endocrinology|October 15, 2020
Outcomes in unilateral primary aldosteronism after surgical or medical therapyTroy H Puar, Lih M Loh, Wann J Loh, et al.
Nature Communications|July 25, 2022
Warming and redistribution of nitrogen inputs drive an increase in terrestrial nitrous oxide emission factorE Harris, L Yu, Y-P Wang, et al.
Circulation Research|August 12, 2021
Dach1 Extends Artery Networks and Protects Against Cardiac InjuryBrian Raftrey, Ian Williams, Pamela E Rios Coronado, et al.
Journal of the Endocrine Society|September 20, 2021
Tolerability and Efficacy of Long-Term Medical Therapy in Primary AldosteronismFengjie Tang, Lih M Loh, Roger S Foo, et al.
Cancer Discovery|November 20, 2025
DNMT3A R882H Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell FrequencyThomas Köhnke, Daiki Karigane, Eleanor Hilgart, et al.
Blood Cancer Discovery|October 30, 2025
Intra-Leukemic Interferon Signaling Suppresses Expansion and Mediates Chemoresistance in Human AMLDaiki Karigane, Amy C Fan, Toshinobu Nishimura, et al.
Biorxiv : the Preprint Server for Biology|November 18, 2024
DNMT3A<sup>R882H</sup> Is Not Required for Disease Maintenance in Primary Human AML, but Is Associated With Increased Leukemia Stem Cell FrequencyThomas Köhnke, Daiki Karigane, Eleanor Hilgart, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
Phthalazinones. Part 1: The design and synthesis of a novel series of potent inhibitors of poly(ADP-ribose)polymeraseVincent M Loh, Xiao-ling Cockcroft, Krystyna J Dillon, et al.
Pageof 22